Symbol: |
SLC29A2
|
Description: |
solute carrier family 29 (nucleoside transporters), member 2 [Source:HGNC Symbol;Acc:11004]
|
Location: |
Chr11:66129992-66139685[-]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:244
Gene |
Compound |
Gen_sig |
Exp_pattern |
SLC29A2 |
NSC 527353 |
0.01 |
Down |
SLC29A2 |
9-AC |
0.002 |
Up |
SLC29A2 |
NSC 606398 |
0.015 |
Down |
SLC29A2 |
Camptothecin ethylglycinate ester hydrochloride |
0.029 |
Up |
SLC29A2 |
Camptothecin hemisuccinate sodium salt |
0.044 |
Up |
SLC29A2 |
Camptothecin lysinate HCl |
0.029 |
Up |
SLC29A2 |
3-Deazaneplanocin, hydrochloride |
0.046 |
Down |
SLC29A2 |
Carbonimidodithioic acid, [5-(4-nitrophenyl)-1,3,4- thiadiazol-2-yl]-, dimethyl ester |
0.005 |
Up |
SLC29A2 |
2-Propen-1-one, 3-(l,3-benzodioxol-5-yl)-1-(1,4-dioxo- 2,6,7-trimethylquinoxalin-3-yl)- |
0.012 |
Up |
SLC29A2 |
4H-1-Benzothiopyran-4-one, 2-(methylsulfonyl)- |
0.028 |
Down |
SLC29A2 |
ANTINEOPLASTIC-625543 |
0.008 |
Down |
SLC29A2 |
9-AMINO-20-CAMPTOTHECIN |
0.028 |
Up |
SLC29A2 |
4,8-Ethenobenzo[1,2-c:4,5-c']dipyrrole-1,3,5,7-tetrone, 2,6-bis(3-cyanophenyl)-1,2,3,3a,4,4a,5,6,7,7a,8,8a- dodecahydro- |
0.012 |
Up |
SLC29A2 |
L-Lysine, N-[(methylamino)carbonyl]-N'-(phenylmethoxy- carbonyl)-, phenylmethyl ester |
0.038 |
Up |
SLC29A2 |
NSC 637128 |
0.034 |
Down |
Expression pattern: Sensitivity / Resistance
Total:17 Current:4
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:21
Total:2 Current:1
[First] [Prev]  Next Last 
|
miRNA:
~ Export ~
|
Records:25
Total:2 Current:1
[First] [Prev]  Next Last 
|